$24.78
0[0.00%]
At close: Apr 18
$24.78
0[0.00%]
PreMarket: 4:00PM EDT
4D Molecular Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of 4D Molecular Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/08/2024 | PM | FDMT | Q1 | -$0.88 | -$0.72 | — | — | $298.00K | $840.00K | — | — | Get Alert |
02/29/2024 | PM | FDMT | Q4 | -$0.84 | -$0.74 | -$0.77 | -4.05% | $1.25M | $2.06M | -$17.00K | -100.83% | Get Alert |
11/09/2023 | PM | FDMT | Q3 | -$0.79 | -$0.54 | -$0.24 | 55.56% | $500.00K | $9.87M | $20.20M | 104.70% | Get Alert |
08/09/2023 | PM | FDMT | Q2 | -$0.87 | -$0.81 | -$0.77 | 4.94% | $162.00K | $850.00K | $239.00K | -71.88% | Get Alert |
05/10/2023 | PM | FDMT | Q1 | -$0.82 | -$0.90 | -$0.88 | 2.22% | $1.22M | $1.03M | $298.00K | -71.07% | Get Alert |
03/15/2023 | PM | FDMT | Q4 | -$0.85 | -$0.79 | -$0.84 | -6.33% | $92.00K | $3.01M | $1.25M | -58.57% | Get Alert |
11/08/2022 | PM | FDMT | Q3 | -$0.82 | -$0.91 | -$0.79 | 13.19% | $1.37M | — | $500.00K | — | Get Alert |
08/11/2022 | PM | FDMT | Q2 | -$0.28 | -$0.85 | -$0.87 | -2.35% | $14.58M | $860.00K | $162.00K | -81.16% | Get Alert |
05/12/2022 | PM | FDMT | Q1 | -$0.61 | — | -$0.82 | — | $2.00M | — | $1.22M | — | Get Alert |
03/28/2022 | PM | FDMT | Q4 | — | -$0.86 | -$0.85 | 1.16% | — | — | $92.00K | — | Get Alert |
11/10/2021 | PM | FDMT | Q3 | -$1.51 | -$0.80 | -$0.82 | -2.50% | $7.42M | $170.00K | $1.37M | 703.53% | Get Alert |
08/12/2021 | PM | FDMT | Q2 | -$2.92 | -$0.68 | -$0.28 | 58.82% | $3.63M | $14.58M | $14.58M | 0.00% | Get Alert |
05/13/2021 | PM | FDMT | Q1 | -$2.54 | -$1.17 | -$0.61 | 47.86% | $3.50M | — | $2.00M | — | Get Alert |
4D Molecular Therapeutics (FDMT) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
The Actual EPS was $-0.77, which missed the estimate of $-0.74.
The Actual Revenue was $-17K, which missed the estimate of $2.1M.
Browse earnings estimates, EPS, and revenue on all stocks.